【24h】

The Vascular Wall as a Source of Stem Cells

机译:血管壁作为干细胞的来源

获取原文

摘要

We have characterized the emerging hematopoietic system in the human embryo and fetus. Two embryonic organs, the yolk sac and aorta, support the primary emergence of hematopoietic stem cells (HSCs), but only the latter contributes lymphomyeloid stem cells for definitive, adult-type hematopoiesis. A common feature of intra- and extraembryonic hematopoiesis is that in both locations hematopoietic cells emerge in close vicinity to vascular endothelial cells. We have provided evidence that a population of angiohematopoietic mesodermal stem cells, marked by the expression of flk-1 and the novel BB9/ACE antigen, migrate from the paraaortic splanchnopleura into the ventral part of the aorta, where they give rise to hemogenic endothelial cells and, in turn, hematopoietic cells. HSCs also appear to develop from endothelium in the embryonic liver and fetal bone marrow, albeit at a much lower frequency. This would imply that the organism does not function during its whole life on a stock of hematopoietic stem cells established in the early embryo, as is usually accepted. We next examined whether the vessel wall can contribute stem cells for other cell lineages, primarily in the model of adult skeletal muscle regeneration. By immunohistochemistry and flow cytometry, we documented the existence in skeletal muscle, besides genuine endothelial and myogenic cells, of a subset of satellite cells that coexpress endothelial cell markers. This suggested the existence of a continuum of differentiation from vascular cells to endothelial cells that was confirmed in long-term culture. The regenerating capacity of these cells expressing both myogenic and endothelial markers is being investigated in skeletal and cardiac muscle, and the results are being compared with those generated by satellite cells. Altogether, these results point to a generalized progenitor potential of a subset of endothelial, or endothelium-like, cells in blood vessel walls, in pre- and postnatal life.
机译:我们在人体胚胎和胎儿中表征了新兴造血系统。两种胚胎器官,卵黄囊和主动脉,支持造血干细胞的主要出现(HSC),但只有后者才能为淋巴瘤淋巴结干细胞进行最终,成人型血液血液血液。血管内血管内血管内和血管内血管缺陷的共同特征是,在两个位置造血细胞近距离血管内皮细胞。我们已经提供了一种证据表明,通过FLK-1和新型BB9 / Ace抗原的表达,血管发育性中胚层干细胞的血液致病性和抗原的群体迁移到与主动脉的腹侧部分迁移到腹侧部分而且,又造血细胞。 HSCs还似乎从胚胎肝脏和胎儿骨髓内的内皮产生,尽管频率远低。这意味着,在早期胚胎中建立的造血干细胞的一生中,生物体在整个生命中都没有起作用,如通常被接受的那样。我们接下来检查血管壁是否可以为其他细胞谱系产生干细胞,主要是在成人骨骼肌再生的模型中。通过免疫组织化学和流式细胞术,除了正版内皮和肌基细胞,卫星细胞的子集外,我们记录了骨骼肌的存在,该卫星细胞的子集中内皮细胞标记物。这表明存在从长期培养中证实的内皮细胞对内皮细胞的连续性的存在。在骨骼和心肌中研究表达肌菌和内皮标记物的这些细胞的再生能力,并将结果与​​卫星细胞产生的结果进行比较。总共,这些结果指向血管壁中的内皮或内皮样细胞的常见祖潜力,在预后寿命中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号